Supplementary Material for: High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors
Johan Botling(Uppsala University Hospital), Joakim Crona(Uppsala University), Guido Rindi(Agostino Gemelli University Polyclinic), Josefine Kjaer(Uppsala University), Per Hellman(Uppsala University Hospital), Olov Norlén(Uppsala University), Britt Skogseid(Uppsala University), Ángela Lamarca(Hospital Universitario Fundación Jiménez Díaz), Staffan Welin(Uppsala University), Barbro Eriksson, D. Bajic(Uppsala University), Vincent Lönngren(Uppsala University)
Cited by 0
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863